美股市场个股详情
MNOV 美第奇新星生物技术
- 1.330
- +0.010+0.76%
收盘价 05/07 16:00 (美东)
6523.15万总市值-7823市盈率TTM
1.400最高价1.330最低价4.02万股成交量1.340今开1.320昨收5.54万成交额0.10%换手率亏损市盈率(静)4904.62万总股本2.66052周最高1.05市净率5623.29万流通值1.26052周最低--股息TTM4228.04万流通股16.120历史最高--股息率TTM5.30%振幅1.260历史最低1.376平均价1股每手
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
美第奇新星生物技术股票讨论区
Medicinova Receives Issue Notification for New Patent Covering Extended-Release Formulations of Mn-166 (Ibudilast)
WSJ· 2 mins ago
MediciNova Secures Notice Of Grant For New Patent Covering MN-166 (Ibudilast) For Treatment Of Macular Injury In China
In reaction to earnings/guidance:
• $The Trade Desk(TTD.US)$+17%, $Workiva(WK.US)$ +15.3%, $Arlo Technologies(ARLO.US)$ +12%, $Array Technologies(ARRY.US)$ +10.3%, $Everbridge(EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals(CPRX.US)$ +9.4%, $奥洛兹美医疗(HALO.US)$ +8.7%, $Velo3D(VLD.US)$ +7.6%, $CyberArk(CYBR.US)$ + 6.2%, $美国血液技术(HAE.US)$ +5.8%, $Jackson Financial(JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise(AXON.US)$ +4.8%,...
$AMC院线(AMC.US)$
$AMC院线(AMC.US)$
$Indaptus Therapeutics(INDP.US)$
$Applied DNA Sciences(APDN.US)$
$美第奇新星生物技术(MNOV.US)$
• $DBV Technologies(DBVT.US)$ +23.5% (positive topline results from Phase 3 EPITOPE Trial)
• $Aldeyra Therapeutics(ALDX.US)$ +19.2% (achieves primary endpoint in phase 3 tranquility-2 trial)
• $美第奇新星生物技术(MNOV.US)$ +11.9% (top-line results from phase 2 clinical trial of MN-166)
• $Torrid(CURV.US)$ +11% (In reaction to earnings/guidance)
• $诺瓦瓦克斯医药(NVAX.US)$ +10.1% (FDA advisory committee recommends EUA for its COVID-19 v...
暂无评论